Insights & events

WEBINAR
2023 High-cost claims and injectable drug trends analysis

 May 17, 2023    2-3pm ET

Please join Sun Life’s President of Health and Risk Solutions, Jennifer Collier, VP, Actuarial & Risk Management, Mike Huppert, and Director of Clinical Services, Lisa Hundertmark for a presentation and Q&A session hosted by VP, Chief Medical Officer and Head of PinnacleCare, Miles Varn on our 11th annual high-cost claims and injectable drug trends analysis.

Register now

WEBINAR
2023 High-cost claims and injectable drug trends analysis

 May 17, 2023    2-3pm ET

Please join Sun Life’s President of Health and Risk Solutions, Jennifer Collier, VP, Actuarial & Risk Management, Mike Huppert, and Director of Clinical Services, Lisa Hundertmark for a presentation and Q&A session hosted by VP, Chief Medical Officer and Head of PinnacleCare, Miles Varn on our 11th annual high-cost claims and injectable drug trends analysis.

Register now

  • June 28, 2024

    Gene Therapies Update: Hemophilia

    The FDA recently approved gene therapies used to treat hemophilia A and B. This Sun Life Bright Paper dives deeper into Roctavian and Hemgenix, other treatments, their costs, and more. This is a big step forward in hemophilia care!

  • May 15, 2024

    Mental health impacts of a breast cancer diagnosis

    Breast cancer is one of the most common cancers in women in the U.S., and can take a severe emotional and mental toll on patients and their families. Sun Life's Bright Paper discusses the link between mental health and breast cancer, barriers to access treatment, recommendations, and more.

  • April 02, 2024

    Spotlight on kidney disease: Assessing and addressing the risks

    Kidney related conditions consistently rank within Sun Life's top 10 high-cost claims, and having kidney disease is surprisingly common. Sun Life's Bright Paper addresses kidney disease risk factors, barriers to care, and recommendations for employers to help employees manage their health, while also controlling claim costs.

  • March 22, 2024

    Arthritis cost review: High-cost prescription and injectable drugs update

    Arthritis, the leading cause of work disability, affects 1 in 4 adults and has no cure yet. In this article, Sun Life shares insights on the long-term condition, and covers the impacts it can have on employees and employers, high-cost arthritis claims, and research on current and potential drug therapies.

  • February 28, 2024

    2024 Updates and 2023 Year in Review on Leave and Accommodations Webinar

    Watch Marjory Robertson, AVP & Senior Counsel, Sun Life and Abigail O’Connell, Senior Counsel, Sun Life, for  a recap of 2023 legal and compliance developments related to leave and accommodation law. They also provided updates on the federal Pregnancy Workers Fairness Act, and other compliance issues trending in 2024. 

  • January 16, 2024

    2024 Future Forecast Video Series: Improving the Medical Moment

    What's top of mind for Sun Life in 2024? Sun Life leaders share insights on the importance of gene therapies, the benefits of receiving care at home, and legislative impacts on healthcare policy in 2024.

  • September 20, 2023

    2023 Updates on Leave and Accommodation laws

    Watch as Marjory Robertson, AVP & Senior Counsel, Sun Life U.S. and Abigail O’Connell, Senior Counsel, recap the latest 2023 leave and accommodation-related compliance developments. 

    They also include a section on recent jury verdicts involving the FMLA and the ADA, which is always an audience favorite.

  • May 17, 2023

    2023 High-cost claims and injectable drug trends analysis

    For the past eleven years, Sun Life has shared our data and insights with the self-funded marketplace to help employers and brokers understand trends around the highest-cost claims. While a lot has changed over the eleven years, one thing has not: our commitment to providing you with actionable insights that can help you stay informed about conditions and medications most likely to result in a high-cost claim, and steps you can take to manage that risk as a self-funded employer. 

    Join our team of experts dive deeper into our key insights and provide actionable recommendations for employers.

  • February 08, 2023

    2023 Future Forecast with Jennifer Collier and James Slotnick

    What's top of mind for Sun Life leaders? Sun Life's SVP of Health and Risk Solutions, Jennifer Collier and James Slotnick, Head of Government Relations share their perspectives on the evolving industry landscape in this 2023 Future Forecast.

  • February 06, 2023

    Introduction to Gene Therapies (3rd edition)

    Learn more about recently approved Hemgenix in the treatment of Hemophilia B, the gene therapy pipeline, the approval process, and what gene therapies are, in our second edition of the Introduction to Gene Therapies paper.